Bio Path Holdings Inc expected to post a loss of 45 cents a share - Earnings Preview

Bio Path Holdings

11/11/2022 14:32

* Bio Path Holdings Inc  BPTH.OQ   BPTH.O  is expected
to show no
change in quarterly revenue when it reports  results on November
15. 
    * 
    * ​Refinitiv's mean analyst estimate for Bio Path Holdings
Inc is
for a loss of 45 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $11​, above​ its last closing price of $1.46. ​​​

This summary was machine generated November 11 at 14:32 GMT. 
All figures in US dollars  unless otherwise stated